33. B-Cell Depleting Therapies and COVID-19
ACR on Air
00:00
The Importance of German Center Responses in the Treatment of Lupus
The development of Everschield and Pax-Lovid has really made me feel a little bit better about giving me some depressive drugs to our patients. I think specific, I'm so anchored in vaccine responses now. What have you learned about either B cells or our use of vaccines that can maybe improve the way that we manage our patients going forward? The question here is about, if you happen to hold medicines for optimizing acute antibody responses, when you restarted these GC responses are obviously still ongoing. Is that going to reduce antibody quality? Right.
Transcript
Play full episode
